• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕米膦酸盐治疗成骨不全症时的高钙血症

Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.

作者信息

Williams C J, Smith R A, Ball R J, Wilkinson H

机构信息

Department of Paediatrics, York District Hospital.

出版信息

Arch Dis Child. 1997 Feb;76(2):169-70. doi: 10.1136/adc.76.2.169.

DOI:10.1136/adc.76.2.169
PMID:9068314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1717065/
Abstract

The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia in the same child. The bisphosphonates may have other roles in osteogenesis imperfecta by decreasing bone turnover.

摘要

据报道,一名成骨不全患儿在骨折后固定期间出现反复症状性高钙血症,对双膦酸盐药物帕米膦酸钠有反应。口服氯膦酸盐对预防该患儿的固定性高钙血症有效。双膦酸盐通过降低骨转换率,在成骨不全中可能还有其他作用。

相似文献

1
Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.帕米膦酸盐治疗成骨不全症时的高钙血症
Arch Dis Child. 1997 Feb;76(2):169-70. doi: 10.1136/adc.76.2.169.
2
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全的双膦酸盐治疗
Cochrane Database Syst Rev. 2014 Jul 23(7):CD005088. doi: 10.1002/14651858.CD005088.pub3.
3
Bone healing in children with osteogenesis imperfecta treated with bisphosphonates.双膦酸盐治疗成骨不全症儿童的骨愈合情况。
J Pediatr Orthop. 2005 May-Jun;25(3):332-5. doi: 10.1097/01.bpo.0000152940.10487.c9.
4
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.静脉注射帕米膦酸盐和氯膦酸盐治疗恶性肿瘤高钙血症的随机双盲对照研究
Br J Cancer. 1995 Nov;72(5):1289-93. doi: 10.1038/bjc.1995.502.
5
Bone densitometry in pediatric patients treated with pamidronate.接受帕米膦酸盐治疗的儿科患者的骨密度测定
Pediatr Radiol. 2005 May;35(5):511-7. doi: 10.1007/s00247-004-1393-3. Epub 2005 Jan 18.
6
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.79名患有I型、III型和IV型成骨不全症的瑞典儿童接受帕米膦酸盐治疗后的骨折率降低、药物遗传学及骨密度反应
Bone. 2016 Jun;87:11-8. doi: 10.1016/j.bone.2016.02.015. Epub 2016 Mar 5.
7
[Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta].[跨学科方法在成骨不全患者长骨骨折愈合中的作用]
Acta Chir Orthop Traumatol Cech. 2008 Jun;75(3):185-9.
8
Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
Intensive Crit Care Nurs. 1997 Feb;13(1):58-9. doi: 10.1016/s0964-3397(97)80763-x.
9
New trends in the treatment of osteogenesis imperfecta type III - own experience.III型成骨不全症治疗的新趋势——个人经验
Ortop Traumatol Rehabil. 2008 Nov-Dec;10(6):593-601.
10
Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.维生素D中毒通过增加骨吸收导致高钙血症,而骨吸收对帕米膦酸盐有反应。
Clin Endocrinol (Oxf). 1995 Nov;43(5):531-6. doi: 10.1111/j.1365-2265.1995.tb02916.x.

引用本文的文献

1
Administration of Denosumab Preserves Bone Mineral Density at the Knee in Persons With Subacute Spinal Cord Injury: Findings From a Randomized Clinical Trial.地诺单抗给药可保留亚急性脊髓损伤患者膝关节的骨矿物质密度:一项随机临床试验的结果
JBMR Plus. 2020 Jun 25;4(8):e10375. doi: 10.1002/jbm4.10375. eCollection 2020 Aug.
2
Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.唑来膦酸给药未能预防急性脊髓损伤患者膝关节骨质流失:一项观察性队列研究。
J Bone Miner Metab. 2015 Jul;33(4):410-21. doi: 10.1007/s00774-014-0602-x. Epub 2014 Aug 27.
3
Current and emerging treatments for the management of osteogenesis imperfecta.目前和新兴的治疗方法用于管理成骨不全症。
Ther Clin Risk Manag. 2010 Sep 7;6:367-81. doi: 10.2147/tcrm.s5932.
4
The role of bisphosphonates in diseases of childhood.双膦酸盐在儿童疾病中的作用。
Eur J Pediatr. 2003 Nov;162(11):735-51. doi: 10.1007/s00431-003-1298-4. Epub 2003 Sep 11.
5
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.长期静脉注射双膦酸盐治疗成骨不全症的有益效果。
Arch Dis Child. 2002 May;86(5):356-64. doi: 10.1136/adc.86.5.356.
6
Osteogenesis imperfecta: practical treatment guidelines.成骨不全症:实用治疗指南。
Paediatr Drugs. 2000 Nov-Dec;2(6):465-88. doi: 10.2165/00128072-200002060-00005.

本文引用的文献

1
Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Bone Miner. 1986 Feb;1(1):27-39.
2
Is APD a promising drug in the treatment of severe osteogenesis imperfecta?APD是治疗重度成骨不全症的一种有前景的药物吗?
J Pediatr Orthop. 1988 Jan-Feb;8(1):71-2. doi: 10.1097/01241398-198801000-00017.
3
Osteogenesis imperfecta in childhood: cardiac and renal manifestations.儿童成骨不全症:心脏和肾脏表现
Eur J Pediatr. 1989 Dec;149(3):184-7. doi: 10.1007/BF01958277.
4
Hypercalciuria in children severely affected with osteogenesis imperfecta.患有严重成骨不全症儿童的高钙尿症。
J Pediatr. 1991 Jul;119(1 Pt 1):51-7. doi: 10.1016/s0022-3476(05)81038-8.
5
Genetic heterogeneity in osteogenesis imperfecta.成骨不全症中的遗传异质性。
J Med Genet. 1979 Apr;16(2):101-16. doi: 10.1136/jmg.16.2.101.